Grantryl 1 mg/1 ml & 3 mg/3 ml Injection
PDF Leaflet Revision Date: 28 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Management of nausea and vomiting induced by chemotherapy, radiotherapy, and post-operative.
Dosage (summary)
Adults: 1-3 mg IV prior to chemotherapy/radiotherapy; max 9 mg/24h. PONV: 1 mg IV prior to anesthesia.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated during pregnancy and lactation.
Key Drug Interactions
- Phenobarbital may increase clearance
- Co-administer with benzodiazepines and neuroleptics
Contraindications
- Hypersensitivity
- Children under 2 years
- Congenital long QT syndrome
Common side effects
- Headache
- Dizziness
- Somnolence
- Abdominal pain
- Constipation
Counselling Points
- Avoid driving if somnolence occurs
- Report any signs of myocardial ischemia
Serious warnings
- May cause dysrhythmias
- Monitor for myocardial ischemia
- Max 9 mg/24h
Important Disclaimer
The Grantryl 1 mg/1 ml & 3 mg/3 ml Injection professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
